Stratasys Broadens Additive Manufacturing Reach with New Software, Materials, and Printer
Event summary
- Stratasys unveiled new application-driven software capabilities, materials, and platform enhancements aimed at accelerating additive manufacturing adoption.
- The J850 Core printer, a lower-cost PolyJet system, is planned for booking by the end of April and targets engineering teams focused on functional prototyping.
- Stratasys and Shin-Etsu introduced P3 MED Silicone 25A, a biocompatible silicone material for medical devices, exclusively for Origin printers.
- The GrabCAD Additive App Suite, developed by trinckle, will launch later this summer with 10 apps, expanding to 15 by November.
- Stratasys released SAF PA12 - Powered by Evonik, offering a 14% lower total cost of ownership compared to current SAF PA12 materials.
The big picture
Stratasys is attempting to broaden the appeal of additive manufacturing by lowering barriers to entry and expanding material options, targeting both industrial and medical applications. This strategy reflects a broader industry trend towards democratizing 3D printing and moving beyond prototyping into production-scale deployments. The partnership with Shin-Etsu and trinckle signals a shift towards integrated solutions, rather than standalone hardware sales, which could reshape Stratasys' business model.
What we're watching
- Adoption Rate
- The success of the GrabCAD Additive App Suite will hinge on its ability to genuinely simplify workflows and drive adoption beyond specialist AM teams, potentially impacting Stratasys' overall software revenue.
- Material Competition
- The introduction of biocompatible silicone will likely intensify competition in the 3D-printed medical device materials space, requiring Stratasys to defend its exclusive partnership with Shin-Etsu.
- Pricing Pressure
- The lower cost of SAF PA12 could put pressure on Stratasys' margins and necessitate a broader review of pricing strategies across its materials portfolio.
Related topics